Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali

Background. In 2010, Africa's first preventive meningococcal mass vaccination campaign was launched using a newly developed Neisseria meningitidis group A (NmA) polysaccharide–tetanus toxoid conjugate vaccine, PsA-TT (MenAfriVac), designed specifically for the meningitis belt. Given PsA-TT'...

Descripción completa

Detalles Bibliográficos
Autores principales: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Dembélé, Awa Traoré Eps, Onwuchekwa, Uma, Townsend, Kelly, Boukary, Rahamatou M., Mabey, Lesley, Findlow, Helen, Bai, Xilian, Sow, Samba O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639504/
https://www.ncbi.nlm.nih.gov/pubmed/26553687
http://dx.doi.org/10.1093/cid/civ602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639504/
https://www.ncbi.nlm.nih.gov/pubmed/26553687
http://dx.doi.org/10.1093/cid/civ602

Ejemplares similares